Wala Al Arashi

Wala Al Arashi is a Researcher in the Department of Pediatrics at Erasmus MC, Rotterdam, Netherlands, specializing in bleeding disorders with emphasis on von Willebrand disease, platelet function disorders, and pharmacokinetics. Her work bridges clinical hematology and diagnostic innovation to improve patient management.

Her research portfolio includes:

• Pharmacokinetics of factor replacement in pregnancy
• Diagnostic testing for platelet-dense granule deficiency
• Nanobody-based platelet agonist development
• Patient-reported outcome validation (PROMIS)
• Endothelial colony forming cell heterogeneity

Analysis of her recent publications reveals a cohesive focus on translating laboratory findings into clinical applications for rare bleeding disorders, particularly through consortium-driven studies. Key trends include optimizing von Willebrand factor replacement during delivery, developing rapid point-of-care platelet diagnostics, and establishing standardized outcome measures for patient-centered care.

Dr. Al Arashi actively participates in multiple collaborative networks including the SYMPHONY consortium, Thrombocytopathy in the Netherlands (TiN) study group, OPTI-CLOT/To WiN pregnancy study, and the Dutch PROMIS implementation group for inherited bleeding disorders, demonstrating strong interdisciplinary engagement across hematology research.